Crinetics Pharmaceuticals (CRNX) Stock Price
$30.5 1.1%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
7 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Crinetics Pharmaceuticals, AI stock picks, stock alerts and much more.
CRNX AI Stock Analysis
AI stock analysis for CRNX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Crinetics Pharmaceuticals (CRNX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Crinetics Pharmaceuticals (CRNX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Crinetics Pharmaceuticals (CRNX), currently trading at $30.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CRNX
-
Crinetics Pharmaceuticals, Inc.
-
Symbol
CRNX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.9B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.81 1.8% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.95 2.6% |
3 |
 |
Moderna MRNA |
$25.4 0.6% |
3 |
 |
Anavex Life Sciences AVXL |
$9.03 1.2% |
7 |
 |
BridgeBio Pharma BBIO |
$40 0.2% |
7 |
News
CRNX Alternative Data
Web Traffic
Crinetics Pharmaceuticals receives an estimated 13210 monthly visitors to crinetics.com.
-
Web Traffic
13210
-
Change from Previous Month
0.4%
-
3 Month Change
14.3%
-
YoY Change
14.3%
Twitter Followers
Crinetics Pharmaceuticals has 960 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.1% over the last month.
-
Twitter Followers
960
-
Daily Change
0.1%
-
1 Month Change
1.1%
-
3 Month Change
1.7%
-
YoY Change
1.7%
Facebook Engagement
Crinetics Pharmaceuticals has engaged 7 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
7
-
Daily Change
12.5%
-
1 Month Change
22.2%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
34,317 are following Crinetics Pharmaceuticals on LinkedIn, up by 7% over the last month.
-
LinkedIn Followers
34317
-
Daily Change
0.1%
-
1 Month Change
7%
-
3 Month Change
23.7%
Job Postings
Crinetics Pharmaceuticals has an estimated 44 open job postings, which is down -43.6% over the last month.
-
Job Postings
44
-
Daily Change
0%
-
1 Month Change
43.6%
-
3 Month Change
27.9%
-
YoY Change
27.9%
LinkedIn Employees
According to LinkedIn, Crinetics Pharmaceuticals has 464 employees, up by 3.1% over the last month.
-
LinkedIn Employees
464
-
Daily Change
0%
-
1 Month Change
3.1%
-
3 Month Change
13.2%
-
YoY Change
13.2%
Reddit Mentions
Crinetics Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Crinetics Pharmaceuticals has 154 Instagram Followers on its main Instagram account, up by 2.7% over the last month.
-
Instagram Followers
154
-
Daily Change
0%
-
1 Month Change
2.7%
-
3 Month Change
8.5%
-
YoY Change
8.5%
Business Outlook
According to employee reviews, the business outlook among employees at Crinetics Pharmaceuticals is 89 out of 100 (very bullish).
-
Business Outlook
89
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Crinetics Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
CRNX Financials
CRNX Key Metrics
-
Total Revenue
$0
-
Net Income
-$80.6M
-
Earnings per Share
-$0.88
-
Free cash flow
-$65.7M
-
EBITDA
-$94M
-
EBITDA Ratio
0
-
Total Assets
$1.4B
CRNX 2-year Revenue & Income
CRNX 2-year Free Cash Flow
CRNX Technicals
CRNX SMA
CRNX RSI
FAQ
What's the current price of Crinetics Pharmaceuticals (CRNX) Stock?
The price of an Crinetics Pharmaceuticals (CRNX) share is $30.5.
What's the market cap of Crinetics Pharmaceuticals?
The current market cap of Crinetics Pharmaceuticals is 2.9B.
Should I buy or sell CRNX?
Multiple alternative data signals suggest that Crinetics Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Crinetics Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Crinetics Pharmaceuticals stock. The bullish indicators suggest that Crinetics Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Crinetics Pharmaceuticals (CRNX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Crinetics Pharmaceuticals stock, given the bullish outlook.
What are some stocks similar to Crinetics Pharmaceuticals (CRNX) that investors often compare it to?
Crinetics Pharmaceuticals (CRNX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Crinetics Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Crinetics Pharmaceuticals' stock price to be around $32.65 in 2026. Starting from the current price of $30.5, this represents a 7.1% change in price, indicating a bullish outlook for the stock.
How to buy Crinetics Pharmaceuticals (CRNX) Stock?
Crinetics Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Crinetics Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.